Whistleblower lawsuit leads pharmaceutical company to pay nearly $234 million

A whistleblower lawsuit has resulted in a major international pharmaceutical company agreeing to pay nearly $234 million to resolve allegations that it avoided paying hundreds of millions of dollars in Medicaid rebates due to significant drug price increases.